Study details
Enrolling now
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
Yale University
NCT IDNCT06136195ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
63
Study length
about 1.9 years
Ages
21–50
Locations
2 sites in CT
What this study is about
This trial is testing a drug called mavoglurant to see if it helps with alcohol cravings and drinking in people who drink heavily. Participants will be given either mavoglurant or a placebo, and then switch between the two conditions over time.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Mavoglurant
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Psychiatry / Mental Health